25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

BIT (Biotron) Stock Analysis
Buy, Hold or Sell?

Let's analyze Biotron together

I guess you are interested in Biotron Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Biotron’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Biotron’s Price Targets

I'm going to help you getting a better view of Biotron Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Biotron Ltd

I send you an email if I find something interesting about Biotron Ltd.

1. Quick Overview

1.1. Quick analysis of Biotron (30 sec.)










1.2. What can you expect buying and holding a share of Biotron? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
20.0%

What is your share worth?

Current worth
A$0.00
Expected worth in 1 year
A$-0.01
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
A$-0.01
Return On Investment
-514.9%

For what price can you sell your share?

Current Price per Share
A$0.00
Expected price per share
A$0.002 - A$0.003
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Biotron (5 min.)




Live pricePrice per Share (EOD)
A$0.00
Intrinsic Value Per Share
A$-0.03 - A$-0.02
Total Value Per Share
A$-0.03 - A$-0.02

2.2. Growth of Biotron (5 min.)




Is Biotron growing?

Current yearPrevious yearGrowGrow %
How rich?-$158.3k$2m-$2.2m-1,400.1%

How much money is Biotron making?

Current yearPrevious yearGrowGrow %
Making money-$2.2m-$2.2m$36.5k1.6%
Net Profit Margin-208.9%-244.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Biotron (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Biotron?

Welcome investor! Biotron's management wants to use your money to grow the business. In return you get a share of Biotron.

First you should know what it really means to hold a share of Biotron. And how you can make/lose money.

Speculation

The Price per Share of Biotron is A$0.002. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biotron.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biotron, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.00. Based on the TTM, the Book Value Change Per Share is A$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biotron.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-84.0%0.00-84.0%0.00-85.4%0.00-79.1%0.00-80.6%0.00-69.7%
Usd Book Value Change Per Share0.00-83.5%0.00-83.5%0.0050.9%0.00-33.5%0.00-27.8%0.00-4.0%
Usd Dividend Per Share0.000.0%0.000.0%0.00124.8%0.0041.6%0.0048.1%0.0024.0%
Usd Total Gains Per Share0.00-83.5%0.00-83.5%0.00175.7%0.008.1%0.0020.3%0.0020.0%
Usd Price Per Share0.03-0.03-0.02-0.03-0.04-0.04-
Price to Earnings Ratio-16.76--16.76--11.29--20.44--23.00--30.49-
Price-to-Total Gains Ratio-16.86--16.86-5.49--14.92--9.95--24.69-
Price to Book Ratio-236.05--236.05-12.42--46.31--20.88-3.23-
Price-to-Total Gains Ratio-16.86--16.86-5.49--14.92--9.95--24.69-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.001298
Number of shares770416
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (770416 shares)-1,287.13312.66
Gains per Year (770416 shares)-5,148.521,250.62
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-5149-51592963-17131241
20-10297-103085927-34252492
30-15446-154578890-51383743
40-20594-2060611853-68514994
50-25743-2575514817-85646245
60-30891-3090417780-102767496
70-36040-3605320743-119898747
80-41188-4120223707-137029998
90-46337-4635126670-1541411249
100-51485-5150029633-1712712500

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.023.02.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%4.06.00.040.0%10.015.00.040.0%
Dividend per Share0.00.01.00.0%1.00.02.033.3%2.00.03.040.0%2.00.08.020.0%2.00.023.08.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%4.06.00.040.0%10.015.00.040.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Biotron Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.003-0.0030%0.002-264%-0.001-60%-0.001-67%0.000-95%
Book Value Per Share--0.0000.0000%0.002-108%0.001-118%0.002-108%0.002-108%
Current Ratio--0.5790.5790%4.218-86%2.381-76%5.154-89%6.741-91%
Debt To Asset Ratio--1.4951.4950%0.233+542%0.718+108%0.474+215%0.315+374%
Debt To Equity Ratio----0%0.303-100%0.349-100%0.258-100%0.229-100%
Dividend Per Share----0%0.004-100%0.001-100%0.001-100%0.001-100%
Enterprise Value--57258342.08357258342.0830%42441219.426+35%64378909.951-11%77450047.099-26%84198532.540-32%
Eps---0.003-0.0030%-0.003+2%-0.002-6%-0.002-4%-0.002-17%
Ev To Ebitda Ratio---11.361-11.3610%-8.705-23%-18.094+59%-19.722+74%-21.911+93%
Ev To Sales Ratio--34.80534.8050%29.653+17%41.470-16%64.806-46%63.638-45%
Free Cash Flow Per Share---0.003-0.0030%-0.002-8%-0.002-13%-0.002-12%-0.002-22%
Free Cash Flow To Equity Per Share---0.003-0.0030%0.002-260%-0.001-65%-0.001-70%0.000-96%
Gross Profit Margin--1.2521.2520%1.266-1%1.279-2%1.275-2%1.356-8%
Intrinsic Value_10Y_max---0.020----------
Intrinsic Value_10Y_min---0.029----------
Intrinsic Value_1Y_max---0.002----------
Intrinsic Value_1Y_min---0.003----------
Intrinsic Value_3Y_max---0.006----------
Intrinsic Value_3Y_min---0.008----------
Intrinsic Value_5Y_max---0.010----------
Intrinsic Value_5Y_min---0.014----------
Market Cap2654500.096-2070%57602652.08357602652.0830%39419326.426+46%63177102.285-9%74617997.699-23%81280792.940-29%
Net Profit Margin---2.089-2.0890%-2.440+17%-2.105+1%-2.590+24%-2.0870%
Operating Margin---3.088-3.0880%-3.437+11%-2.769-10%-3.368+9%-2.973-4%
Operating Ratio--3.1313.1310%3.520-11%2.812+11%3.286-5%3.084+2%
Pb Ratio-10.878+95%-236.045-236.0450%12.425-2000%-46.315-80%-20.878-91%3.233-7401%
Pe Ratio-0.772+95%-16.762-16.7620%-11.286-33%-20.437+22%-23.005+37%-30.487+82%
Price Per Share0.002-2070%0.0430.0430%0.030+46%0.048-9%0.056-23%0.061-29%
Price To Free Cash Flow Ratio-0.744+95%-16.142-16.1420%-11.981-26%-22.033+36%-24.683+53%-31.394+94%
Price To Total Gains Ratio-0.777+95%-16.859-16.8590%5.486-407%-14.921-11%-9.950-41%-24.692+46%
Quick Ratio--0.5580.5580%4.193-87%2.357-76%5.103-89%6.667-92%
Return On Assets---6.964-6.9640%-0.845-88%-3.089-56%-2.093-70%-1.468-79%
Return On Equity----0%-1.1010%-1.2160%-0.9970%-1.0290%
Total Gains Per Share---0.003-0.0030%0.005-148%0.000-1127%0.001-512%0.001-517%
Usd Book Value---158376.768-158376.7680%2059053.744-108%869902.293-118%1928454.436-108%1966320.276-108%
Usd Book Value Change Per Share---0.002-0.0020%0.001-264%-0.001-60%-0.001-67%0.000-95%
Usd Book Value Per Share--0.0000.0000%0.002-108%0.001-118%0.001-108%0.001-108%
Usd Dividend Per Share----0%0.002-100%0.001-100%0.001-100%0.000-100%
Usd Enterprise Value--37160664.01237160664.0120%27544351.407+35%41781912.559-11%50265080.567-26%54644847.618-32%
Usd Eps---0.002-0.0020%-0.002+2%-0.002-6%-0.002-4%-0.001-17%
Usd Free Cash Flow---2315999.334-2315999.3340%-2135232.715-8%-2010742.400-13%-2049514.872-12%-1805192.721-22%
Usd Free Cash Flow Per Share---0.002-0.0020%-0.002-8%-0.002-13%-0.002-12%-0.001-22%
Usd Free Cash Flow To Equity Per Share---0.002-0.0020%0.001-260%-0.001-65%-0.001-70%0.000-96%
Usd Market Cap1722770.562-2070%37384121.20237384121.2020%25583142.850+46%41001939.383-9%48427080.506-23%52751234.618-29%
Usd Price Per Share0.001-2070%0.0280.0280%0.019+46%0.031-9%0.036-23%0.040-29%
Usd Profit---2230304.076-2230304.0760%-2266805.134+2%-2100677.359-6%-2139192.134-4%-1850107.675-17%
Usd Revenue--1067678.9861067678.9860%928902.667+15%1002688.126+6%895606.111+19%939442.946+14%
Usd Total Gains Per Share---0.002-0.0020%0.004-148%0.000-1127%0.000-512%0.000-517%
 EOD+2 -6MRQTTM+0 -0YOY+17 -223Y+6 -335Y+8 -3110Y+6 -33

3.3 Fundamental Score

Let's check the fundamental score of Biotron Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.772
Price to Book Ratio (EOD)Between0-1-10.878
Net Profit Margin (MRQ)Greater than0-2.089
Operating Margin (MRQ)Greater than0-3.088
Quick Ratio (MRQ)Greater than10.558
Current Ratio (MRQ)Greater than10.579
Debt to Asset Ratio (MRQ)Less than11.495
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-6.964
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Biotron Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.787
Ma 20Greater thanMa 500.003
Ma 50Greater thanMa 1000.003
Ma 100Greater thanMa 2000.006
OpenGreater thanClose0.002
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Biotron Ltd

Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. Biotron Limited was incorporated in 1999 and is based in Sydney, Australia.

Fundamental data was last updated by Penke on 2025-05-30 04:43:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Biotron earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Biotron to theΒ Biotechnology industry mean.
  • A Net Profit Margin of -208.9%Β means thatΒ $-2.09 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biotron Ltd:

  • The MRQ is -208.9%. The company is making a huge loss. -2
  • The TTM is -208.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-208.9%TTM-208.9%0.0%
TTM-208.9%YOY-244.0%+35.1%
TTM-208.9%5Y-259.0%+50.1%
5Y-259.0%10Y-208.7%-50.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-208.9%-94.6%-114.3%
TTM-208.9%-144.8%-64.1%
YOY-244.0%-198.4%-45.6%
3Y-210.5%-256.0%+45.5%
5Y-259.0%-348.5%+89.5%
10Y-208.7%-479.9%+271.2%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Biotron is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Biotron to theΒ Biotechnology industry mean.
  • -696.4% Return on Assets means thatΒ Biotron generatedΒ $-6.96 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biotron Ltd:

  • The MRQ is -696.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -696.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-696.4%TTM-696.4%0.0%
TTM-696.4%YOY-84.5%-611.9%
TTM-696.4%5Y-209.3%-487.1%
5Y-209.3%10Y-146.8%-62.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-696.4%-11.4%-685.0%
TTM-696.4%-11.4%-685.0%
YOY-84.5%-11.2%-73.3%
3Y-308.9%-11.7%-297.2%
5Y-209.3%-11.9%-197.4%
10Y-146.8%-13.8%-133.0%
4.3.1.3. Return on Equity

Shows how efficient Biotron is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Biotron to theΒ Biotechnology industry mean.
  • 0.0% Return on Equity means Biotron generated $0.00Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biotron Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-110.1%+110.1%
TTM-5Y-99.7%+99.7%
5Y-99.7%10Y-102.9%+3.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.3%+13.3%
TTM--14.5%+14.5%
YOY-110.1%-14.3%-95.8%
3Y-121.6%-16.9%-104.7%
5Y-99.7%-17.2%-82.5%
10Y-102.9%-19.9%-83.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Biotron Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Biotron is operatingΒ .

  • Measures how much profit Biotron makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Biotron to theΒ Biotechnology industry mean.
  • An Operating Margin of -308.8%Β means the company generated $-3.09 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biotron Ltd:

  • The MRQ is -308.8%. The company is operating very inefficient. -2
  • The TTM is -308.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-308.8%TTM-308.8%0.0%
TTM-308.8%YOY-343.7%+34.9%
TTM-308.8%5Y-336.8%+28.0%
5Y-336.8%10Y-297.3%-39.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-308.8%-204.6%-104.2%
TTM-308.8%-252.1%-56.7%
YOY-343.7%-210.7%-133.0%
3Y-276.9%-220.1%-56.8%
5Y-336.8%-351.8%+15.0%
10Y-297.3%-449.6%+152.3%
4.3.2.2. Operating Ratio

Measures how efficient Biotron is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 3.13 means that the operating costs are $3.13 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Biotron Ltd:

  • The MRQ is 3.131. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.131. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ3.131TTM3.1310.000
TTM3.131YOY3.520-0.389
TTM3.1315Y3.286-0.155
5Y3.28610Y3.084+0.202
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.1312.111+1.020
TTM3.1312.737+0.394
YOY3.5203.107+0.413
3Y2.8123.655-0.843
5Y3.2864.745-1.459
10Y3.0846.397-3.313
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Biotron Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Biotron is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 0.58Β means the company has $0.58 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Biotron Ltd:

  • The MRQ is 0.579. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.579. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.579TTM0.5790.000
TTM0.579YOY4.218-3.639
TTM0.5795Y5.154-4.575
5Y5.15410Y6.741-1.587
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5793.616-3.037
TTM0.5793.745-3.166
YOY4.2184.149+0.069
3Y2.3814.628-2.247
5Y5.1545.766-0.612
10Y6.7416.150+0.591
4.4.3.2. Quick Ratio

Measures if Biotron is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Biotron to theΒ Biotechnology industry mean.
  • A Quick Ratio of 0.56Β means the company can pay off $0.56 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biotron Ltd:

  • The MRQ is 0.558. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.558. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.558TTM0.5580.000
TTM0.558YOY4.193-3.635
TTM0.5585Y5.103-4.545
5Y5.10310Y6.667-1.564
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5582.891-2.333
TTM0.5583.143-2.585
YOY4.1933.843+0.350
3Y2.3574.308-1.951
5Y5.1035.702-0.599
10Y6.6676.505+0.162
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Biotron Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of BiotronΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Biotron to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.49Β means that Biotron assets areΒ financed with 149.5% credit (debt) and the remaining percentage (100% - 149.5%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Biotron Ltd:

  • The MRQ is 1.495. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.495. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.495TTM1.4950.000
TTM1.495YOY0.233+1.262
TTM1.4955Y0.474+1.020
5Y0.47410Y0.315+0.159
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4950.339+1.156
TTM1.4950.356+1.139
YOY0.2330.335-0.102
3Y0.7180.339+0.379
5Y0.4740.349+0.125
10Y0.3150.382-0.067
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Biotron is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Biotron to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biotron Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.303-0.303
TTM-5Y0.258-0.258
5Y0.25810Y0.229+0.030
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.387-0.387
TTM-0.438-0.438
YOY0.3030.414-0.111
3Y0.3490.455-0.106
5Y0.2580.464-0.206
10Y0.2290.504-0.275
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Biotron generates.

  • Above 15 is considered overpriced butΒ always compareΒ Biotron to theΒ Biotechnology industry mean.
  • A PE ratio of -16.76 means the investor is paying $-16.76Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biotron Ltd:

  • The EOD is -0.772. Based on the earnings, the company is expensive. -2
  • The MRQ is -16.762. Based on the earnings, the company is expensive. -2
  • The TTM is -16.762. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.772MRQ-16.762+15.989
MRQ-16.762TTM-16.7620.000
TTM-16.762YOY-11.286-5.476
TTM-16.7625Y-23.005+6.243
5Y-23.00510Y-30.487+7.482
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.772-2.158+1.386
MRQ-16.762-2.033-14.729
TTM-16.762-2.526-14.236
YOY-11.286-3.682-7.604
3Y-20.437-3.711-16.726
5Y-23.005-6.083-16.922
10Y-30.487-6.715-23.772
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biotron Ltd:

  • The EOD is -0.744. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -16.142. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -16.142. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.744MRQ-16.142+15.398
MRQ-16.142TTM-16.1420.000
TTM-16.142YOY-11.981-4.160
TTM-16.1425Y-24.683+8.541
5Y-24.68310Y-31.394+6.711
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.744-2.979+2.235
MRQ-16.142-2.704-13.438
TTM-16.142-3.653-12.489
YOY-11.981-4.430-7.551
3Y-22.033-5.148-16.885
5Y-24.683-8.487-16.196
10Y-31.394-9.328-22.066
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Biotron is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of -236.05 means the investor is paying $-236.05Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Biotron Ltd:

  • The EOD is -10.878. Based on the equity, the company is expensive. -2
  • The MRQ is -236.045. Based on the equity, the company is expensive. -2
  • The TTM is -236.045. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.878MRQ-236.045+225.168
MRQ-236.045TTM-236.0450.000
TTM-236.045YOY12.425-248.470
TTM-236.0455Y-20.878-215.167
5Y-20.87810Y3.233-24.111
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-10.8781.988-12.866
MRQ-236.0451.855-237.900
TTM-236.0452.170-238.215
YOY12.4252.477+9.948
3Y-46.3152.589-48.904
5Y-20.8783.728-24.606
10Y3.2334.372-1.139
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Biotron Ltd.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-06-302021-06-302022-06-302023-06-302024-06-30
Total Stockholder Equity 6,973-3,1103,863-2,7701,0922,0803,173-3,417-244
Net Working Capital  6,878-3,0683,810-2,7991,0122,0643,076-3,386-311
Net Invested Capital  6,973-3,1103,863-2,7701,0922,0803,173-3,417-244



5.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets493
Total Liabilities738
Total Stockholder Equity-244
 As reported
Total Liabilities 738
Total Stockholder Equity+ -244
Total Assets = 493

Assets

Total Assets493
Total Current Assets427
Long-term Assets67
Total Current Assets
Cash And Cash Equivalents 393
Net Receivables 18
Total Current Assets  (as reported)427
Total Current Assets  (calculated)411
+/- 15
Long-term Assets
Property Plant Equipment 13
Long-term Assets Other 54
Long-term Assets  (as reported)67
Long-term Assets  (calculated)67
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities738
Long-term Liabilities0
Total Stockholder Equity-244
Total Current Liabilities
Short-term Debt 7
Accounts payable 286
Other Current Liabilities 445
Total Current Liabilities  (as reported)738
Total Current Liabilities  (calculated)738
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock56,915
Retained Earnings -58,681
Accumulated Other Comprehensive Income 1,522
Total Stockholder Equity (as reported)-244
Total Stockholder Equity (calculated)-244
+/-0
Other
Capital Stock56,915
Cash and Short Term Investments 393
Common Stock Shares Outstanding 902,170
Liabilities and Stockholders Equity 493
Net Debt -386
Net Invested Capital -244
Net Working Capital -311
Property Plant and Equipment Gross 870
Short Long Term Debt Total 7



5.3. Balance Sheets Structured

Currency in AUD. All numbers in thousands.

 Trend2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-30
> Total Assets 
42,221
10,192
8,633
5,909
3,109
2,429
4,814
1,519
2,267
1,064
1,858
2,645
8,462
4,866
1,864
4,616
3,483
2,060
1,619
5,857
7,826
4,327
1,906
4,135
493
4934,1351,9064,3277,8265,8571,6192,0603,4834,6161,8644,8668,4622,6451,8581,0642,2671,5194,8142,4293,1095,9098,63310,19242,221
   > Total Current Assets 
11,021
9,924
8,110
5,518
2,748
2,204
4,669
1,426
2,152
996
1,814
2,613
8,439
4,843
1,799
4,568
3,446
2,030
1,601
5,777
7,719
4,262
1,762
4,031
427
4274,0311,7624,2627,7195,7771,6012,0303,4464,5681,7994,8438,4392,6131,8149962,1521,4264,6692,2042,7485,5188,1109,92411,021
       Cash And Cash Equivalents 
11,021
9,713
7,578
5,375
2,618
2,113
4,624
1,379
2,064
951
1,781
2,145
7,892
4,792
1,764
4,523
3,418
1,987
1,543
5,740
7,661
4,211
1,741
3,984
393
3933,9841,7414,2117,6615,7401,5431,9873,4184,5231,7644,7927,8922,1451,7819512,0641,3794,6242,1132,6185,3757,5789,71311,021
       Short-term Investments 
0
100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000001000
       Net Receivables 
0
111
413
67
66
46
5
41
85
43
9
453
504
2
0
10
0
0
0
0
0
0
0
23
18
182300000001002504453943854154666674131110
       Other Current Assets 
0
-100
29
10
0
7
19
6
4
3
24
16
43
49
35
35
28
43
58
37
58
51
21
24
34
34242151583758432835354943162434619701029-1000
   > Long-term Assets 
31,200
268
522
391
362
224
145
93
115
67
44
32
23
24
65
48
37
29
18
46
107
65
144
104
67
671041446510746182937486524233244671159314522436239152226831,200
       Property Plant Equipment 
0
268
522
391
362
224
143
93
115
67
44
32
23
24
65
48
37
29
18
46
73
31
90
50
13
13509031734618293748652423324467115931432243623915222680
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
34
34
0
0
0
0
000034340000000000000000000
       Intangible Assets 
31,200
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000031,200
       Other Assets 
0
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
34
34
0
0
0
0
000034340000000000002000000
> Total Liabilities 
22
111
143
148
153
150
318
163
424
222
140
244
192
391
475
473
346
620
338
418
853
464
814
962
738
73896281446485341833862034647347539119224414022242416331815015314814311122
   > Total Current Liabilities 
22
111
143
148
153
150
318
163
424
222
140
244
192
391
475
473
346
620
338
412
841
451
751
956
738
73895675145184141233862034647347539119224414022242416331815015314814311122
       Short-term Debt 
0
100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
41
41
6
34
39
7
7393464141000000000000000001000
       Accounts payable 
0
111
138
133
0
0
0
0
227
35
32
89
28
174
267
249
92
344
136
158
310
138
311
285
286
286285311138310158136344922492671742889323522700001331381110
       Other Current Liabilities 
22
111
143
148
153
150
318
163
197
187
108
156
164
217
208
224
254
275
202
254
490
307
405
632
445
44563240530749025420227525422420821716415610818719716331815015314814311122
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
12
12
63
7
0
0763121260000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
0
43
7
0
07430300000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
9
12
20
0
0
002012960000000000000000000
> Total Stockholder Equity
42,221
10,081
8,490
5,761
2,956
2,279
4,496
1,356
1,843
842
1,718
2,400
8,270
4,475
1,389
4,143
3,137
1,440
1,282
5,439
6,973
3,863
1,092
3,173
-244
-2443,1731,0923,8636,9735,4391,2821,4403,1374,1431,3894,4758,2702,4001,7188421,8431,3564,4962,2792,9565,7618,49010,08142,221
   Common Stock
11,163
11,417
11,445
11,445
11,445
12,651
16,865
16,865
19,146
19,921
20,751
23,088
32,549
32,549
32,549
37,208
39,163
40,325
41,439
47,523
52,844
52,844
52,844
56,890
56,915
56,91556,89052,84452,84452,84447,52341,43940,32539,16337,20832,54932,54932,54923,08820,75119,92119,14616,86516,86512,65111,44511,44511,44511,41711,163
   Retained Earnings -58,681-55,264-51,837-49,087-45,945-42,369-40,757-39,164-36,887-34,405-31,681-28,596-24,745-22,859-21,311-19,439-17,663-15,806-12,620-10,483-8,600-5,795-3,065-1,422-142
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
285
0
0
0
1,527
0
01,5270002850000000000000000000
   Treasury Stock0000000000000000000000000
   Other Stockholders Equity 
31,200
-1
-1
0
0
0
0
0
0
0
0
0
0
0
522
522
43
74
85
285
-6,899
-3,757
-1,007
-1,627
0
0-1,627-1,007-3,757-6,89928585744352252200000000000-1-131,200



5.4. Balance Sheets

Currency in AUD. All numbers in thousands.




5.5. Cash Flows

Currency in AUD. All numbers in thousands.




5.6. Income Statements

Currency in AUD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-06-30. Currency in AUD. All numbers in thousands.

Gross Profit (+$)
totalRevenue1,645
Cost of Revenue-40
Gross Profit1,6451,605
 
Operating Income (+$)
Gross Profit1,645
Operating Expense-5,111
Operating Income-5,151-3,466
 
Operating Expense (+$)
Research Development3,625
Selling General Administrative528
Selling And Marketing Expenses867
Operating Expense5,1115,021
 
Net Interest Income (+$)
Interest Income71
Interest Expense-1
Other Finance Cost-0
Net Interest Income70
 
Pretax Income (+$)
Operating Income-5,151
Net Interest Income70
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-5,082-5,221
EBIT - interestExpense = -5,082
-5,082
-3,435
Interest Expense1
Earnings Before Interest and Taxes (EBIT)-5,081-5,081
Earnings Before Interest and Taxes (EBITDA)-5,040
 
After tax Income (+$)
Income Before Tax-5,082
Tax Provision-0
Net Income From Continuing Ops-3,437-5,082
Net Income-3,437
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses5,151
Total Other Income/Expenses Net70-70
 

Technical Analysis of Biotron
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biotron. The general trend of Biotron is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biotron's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Biotron Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Biotron Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.003 < 0.003 < 0.003.

The bearish price targets are: 0.002 > 0.002 > 0.002.

Know someone who trades $BIT? Share this with them.πŸ‘‡

Biotron Ltd Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Biotron Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Biotron Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Biotron Ltd. The current macd is -0.00027097.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Biotron price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Biotron. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Biotron price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Biotron Ltd Daily Moving Average Convergence/Divergence (MACD) ChartBiotron Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Biotron Ltd. The current adx is 55.25.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Biotron shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Biotron Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Biotron Ltd. The current sar is 0.003.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Biotron Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Biotron Ltd. The current rsi is 30.79. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Biotron Ltd Daily Relative Strength Index (RSI) ChartBiotron Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Biotron Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Biotron price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Biotron Ltd Daily Stochastic Oscillator ChartBiotron Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Biotron Ltd. The current cci is -151.32924335.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Biotron Ltd Daily Commodity Channel Index (CCI) ChartBiotron Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Biotron Ltd. The current cmo is -45.40189104.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Biotron Ltd Daily Chande Momentum Oscillator (CMO) ChartBiotron Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Biotron Ltd. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Biotron Ltd Daily Williams %R ChartBiotron Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Biotron Ltd.

Biotron Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Biotron Ltd. The current atr is 0.00034654.

Biotron Ltd Daily Average True Range (ATR) ChartBiotron Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Biotron Ltd. The current obv is 21,341,446.

Biotron Ltd Daily On-Balance Volume (OBV) ChartBiotron Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Biotron Ltd. The current mfi is 83.77.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Biotron Ltd Daily Money Flow Index (MFI) ChartBiotron Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Biotron Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-01-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-28STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-30STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-01-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-02-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-06ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-10ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-13RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-02-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-20MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-28RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-31MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-04-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-04-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-09MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-04-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-30MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-06MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-07MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-05-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-26RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-12MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside

6.3. Candlestick Patterns

Biotron Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Biotron Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.787
Ma 20Greater thanMa 500.003
Ma 50Greater thanMa 1000.003
Ma 100Greater thanMa 2000.006
OpenGreater thanClose0.002
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Biotron with someone you think should read this too:
  • Are you bullish or bearish on Biotron? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biotron? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Biotron Ltd

I send you an email if I find something interesting about Biotron Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Biotron Ltd.

Receive notifications about Biotron Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.